Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection

Journal of Infection and Public Health
Sharef W SharefIbtisam Elnour

Abstract

Urinary tract infection (UTI) is one of the most common community-acquired infections. Different organisms can be the cause of UTI in children, with resistance to antibiotics becoming a significant problem in the choice of treatment. Worldwide studies have documented the prevalence of uropathogens in different countries. However, there is no previous study documenting the incidence of different uropathogens in Oman. We aim to report the most common uropathogens and their antibiotic sensitivity patterns in children presenting with documented, single episode UTI at a tertiary hospital in Oman. A retrospective analysis of all Omani children below 14 years who presented with a case of first documented UTI to SQUH between September 2008 and August 2012 was conducted. Data were obtained from the patients' electronic records in the hospital information system. Data were then analyzed using SSPS (Statistical Package for Social Sciences program, Version 20, IBM, Chicago, IL, USA). In the retrospective review of all urine cultures, 438 positive urine cultures were identified. Out of those, 208 (47.5%) belonged to children with their first episode of UTI. Thirty-three patients were excluded and 75 patients were included in the final analy...Continue Reading

References

May 1, 1988·Archives of Disease in Childhood·J GlennonJ P Rees
Jan 1, 1997·The Pediatric Infectious Disease Journal·A Hoberman, E R Wald
Jan 17, 2003·The New England Journal of Medicine·Alejandro HobermanEllen R Wald
Feb 25, 2003·Archives of Disease in Childhood·S StruthersR Hallett
Sep 6, 2005·Pediatrics·Joseph J ZorcUNKNOWN Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy
May 10, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D M Livermore, A Pearson
Dec 27, 2007·JAMA : the Journal of the American Medical Association·Nader ShaikhEllen R Wald
Jun 10, 2009·International Journal of Antimicrobial Agents·Gian Carlo SchitoAnna Marchese
May 26, 2012·TheScientificWorldJournal·Enrico MaglianoClementina Elvezia Cocuzza
Dec 5, 2012·Annals of Medical and Health Sciences Research·Vu MuonekeRc Ibekwe

❮ Previous
Next ❯

Citations

May 15, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Nadav GraifAvi Peretz
Dec 21, 2020·Journal of Infection and Public Health·Moustafa MoussallyZeina A Kanafan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.